BE in a statement on Thursday said it will leverage its experience to
develop and commercialise the vaccine candidate, which currently is
produced using a proven yeast-based expression technology.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/baylor-college-of-medicine-and-biological-e-sign-licensing-pact-to-develop-covid-19-vaccine/articleshow/77525443.cms
No comments:
Post a Comment